Species: Capnocytophaga ochracea (HMT-0700) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0700: [Body Sites Data]
[Taxon Description]
| Life Page: Capnocytophaga ochracea
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.86 | 0.68 | 0.54 | 0.02 | 0.04 | 0 | 0.10 | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0 | 0.14 | 0 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.09 | 0.08 | 0.02 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| 90thp | 1.88 | 1.45 | 1.34 | 0.05 | 0.11 | 0 | 0.17 | 0.11 | 0.08 | 0.03 | 0.01 | 0.02 | 0 | 0.01 | 0 | 0.35 | 0 | 0 |
| Stdev | 0.87 | 0.71 | 0.56 | 0.02 | 0.10 | 0 | 0.06 | 0.08 | 0.05 | 0.06 | 0.02 | 0.01 | 0 | 0 | 0 | 0.38 | 0.01 | 0.01 |
| Prev(%) | 75.00 | 85.82 | 75.00 | 6.67 | 6.81 | 0 | 25.00 | 0 | 0 | 4.96 | 1.54 | 0 | 0 | 0 | 0 | 12.50 | 0 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to C. ochraceae, C. sp. HMT 412, and C. sp. HMT 903 were assigned one-third to each taxon.
Reads equally close to C. ochraceae, C. sp. HMT 412, and C. sp. HMT 903 were assigned one-third to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.08 | 0.11 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.21 | 0.32 | 0 | 0.01 | 0 | 0.03 | 0 | 0 | 0 | 0 |
| Stdev | 0.23 | 0.26 | 0.01 | 0.01 | 0 | 0.03 | 0.01 | 0.03 | 0 | 0 |
| Prev(%) | 45.95 | 48.65 | 3.38 | 12.16 | 8.78 | 32.43 | 6.76 | 6.76 | 4.73 | 0 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-700 and HMT-902 were assigned to each taxon in proportion to the abundance of HMT-700 and HMT-902 individually at this body site (SUBP).
Reads equidistant to HMT-700 and HMT-864 were assigned to each taxon in proportion to the abundance of HMT-700 and HMT-864 individually at this body site (SUPP).
Reads equidistant to HMT-700 and HMT-902 were assigned to each taxon in proportion to the abundance of HMT-700 and HMT-902 individually at this body site (SUBP).
Reads equidistant to HMT-700 and HMT-864 were assigned to each taxon in proportion to the abundance of HMT-700 and HMT-864 individually at this body site (SUPP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.43 | 0.40 | 0.02 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.04 | 1.24 | 0.01 | 0 | 0 | 0.24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.91 | 0.73 | 0.13 | 0 | 0 | 0.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 78.81 | 74.83 | 14.69 | 0 | 0 | 63.85 | 0 | 0 | 0 | 0 | 0 | 0 | 5.17 | 0 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
No data – the v3v5 region of the 16S rRNA gene does not distinguish this species from its close relatives.
No data – the v3v5 region of the 16S rRNA gene does not distinguish this species from its close relatives.
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.02 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 13.51 | 32.35 | 2.33 | 2.86 | 0 | 2.00 | 0 | 0 | 0 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 1.07 | 0.89 | 0.71 | 0.02 | 0.05 | 0 | 0.09 | 0.03 | 0.01 | 0.01 | 0.02 | 0 | 0 | 0 | 0 | 0.11 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 2.38 | 1.94 | 1.67 | 0.07 | 0.13 | 0 | 0.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 1.18 | 1.10 | 0.77 | 0.04 | 0.17 | 0 | 0.09 | 0.12 | 0.05 | 0.06 | 0.29 | 0 | 0 | 0 | 0 | 0.43 | 0 | 0 |
| Prev(%) | 87.50 | 90.15 | 87.50 | 35.29 | 28.46 | 0 | 87.50 | 6.25 | 8.00 | 8.45 | 0.90 | 4.17 | 0 | 0 | 0 | 7.14 | 0 | 0 |
